Guanhao Biotech Co

Guanhao Biotech Co R&D per Employee

The R&D Spending per Employee of Guanhao Biotech Co (300238.SZ) as of Nov 2, 2026 is 64,388.99 CNY. In the previous year, R&D Spending per Employee was 61,714.95 CNY — a change of 4.33% (higher).

R&D per Employee

64,388.99CNY

YoY

4.33%

Last updated:

R&D Spending per Employee of Guanhao Biotech Co is 2025 64,388.99 CNY. R&D Spending per Employee of Guanhao Biotech Co was 2024 61,714.95 CNY. It decreases by 4.33% higher compared to the previous year.

The Guanhao Biotech Co R&D per Employee history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

R&D per Employee
Date
R&D per Employee
Jan 1, 2018
73,304.18 CNY
Jan 1, 2019
119,370.86 CNY
Jan 1, 2020
58,452.60 CNY
Jan 1, 2021
79,557.05 CNY
Jan 1, 2022
86,207.75 CNY
Jan 1, 2023
75,945.16 CNY
Jan 1, 2024
61,714.95 CNY
Jan 1, 2025
64,388.99 CNY
The Guanhao Biotech Co R&D per Employee history
YEARR&D per EmployeeYoY
64,388.99CNY+4.33%
61,714.95CNY-18.74%
75,945.16CNY-11.90%
86,207.75CNY+8.36%
79,557.05CNY+36.11%
58,452.60CNY-51.03%
119,370.86CNY+62.84%
73,304.18CNY-13.94%
85,176.66CNY+221.40%
26,501.41CNY-10.34%
29,556.75CNY-32.32%
43,669.02CNY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Guanhao Biotech Co Stock analysis

What does Guanhao Biotech Co do? Guanhao Biotech Co Ltd develops and sells regenerative medical materials and implant devices, including biological dura mater patches, chest general surgery department patching membranes (type P and type B), asepsis biological wound-surface protection membranes, type B dura matrix, and intraocular lenses. The company generates revenue through the sale of these products to healthcare providers and medical institutions. Its primary customers are hospitals and surgical departments requiring advanced regenerative solutions for wound care and ophthalmic procedures. The firm also offers related technological services as part of its product portfolio. The company focuses on regenerative medical applications, targeting segments such as neurosurgery, general surgery, and ophthalmology. Its product range addresses specific clinical needs, including dura mater repair, wound protection, and vision correction. By providing specialized medical materials, Guanhao Biotech serves healthcare facilities seeking innovative solutions for patient recovery and surgical outcomes. Guanhao Biotech's core business revolves around the production and distribution of high-value medical devices and materials. The firm's revenue streams are derived from direct sales of its regenerative medical products and associated technological services. Key segments include hospitals, surgical departments, and ophthalmic clinics that utilize its specialized membranes and lenses for patient care. Guanhao Biotech Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Guanhao Biotech Co stock

R&D Spending per Employee of Guanhao Biotech Co is 64,388.99 CNY in 2025.

R&D Spending per Employee of Guanhao Biotech Co changed from 61,714.95 CNY to 64,388.99 CNY, representing a 4.33% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of R&D Spending per Employee Guanhao Biotech Co since 2006 – with annual values, charts, and detailed analysis.

R&D per employee shows the research and development investment allocated per employee. Higher values indicate innovation-focused companies.

R&D Spending per Employee's CNY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track R&D Spending per Employee's Guanhao Biotech Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Workforce — Guanhao Biotech Co

All Key Metrics — Guanhao Biotech Co